SCHEMBL16868513

SCHEMBL16868513

CCOP(=O)(O)c1ccccc1OC

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.68
▸ MEN1 O00255 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ POLB P06746 6/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ PTK2B Q14289 2/20 0.41
▸ CTSD P07339 1/20 0.41
▸ HTT P42858 2/20 0.41
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA4 P22748 1/20 0.40
▸ CA7 P43166 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ CA14 Q9ULX7 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ NR1I2 O75469 1/20 0.39
▸ ALPG P10696 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8752544 0.82 KMT2A (0.51) ALDH1A1MEN1KMT2APOLBCTSD
SCHEMBL17488973 0.81 ALDH1A1 (1.00) ALDH1A1MEN1KMT2APOLBNPC1
SCHEMBL17537482 0.80 ALDH1A1 (0.59) ALDH1A1MEN1KMT2APOLBNPC1
SCHEMBL17489008 0.80 ALDH1A1 (0.59) ALDH1A1MEN1KMT2APOLBNPC1
SCHEMBL20622369 0.79 KMT2A (0.50) ALDH1A1MEN1KMT2APOLBCTSD
SCHEMBL16868477 0.79 ALDH1A1 (0.58) ALDH1A1MEN1KMT2APOLBHTT
SCHEMBL12229785 0.79 ALDH1A1 (0.58) ALDH1A1MEN1KMT2APOLBNPSR1
SCHEMBL10782053 0.79 MEN1 (0.49) ALDH1A1MEN1KMT2APOLBNPC1
SCHEMBL17223165 0.78 ALDH1A1 (0.48) ALDH1A1MEN1KMT2APOLBNPC1
SCHEMBL8752554 0.78 ALDH1A1 (0.43) ALDH1A1MEN1KMT2APOLBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9493494-B2 Phosphinine oxide derivative and preparation method thereof KNU-INDUSTRY COOPERATION FOUNDATION (KR) 2016-11-15 — — US disclosed
US-20150344506-A1 NOVEL PHOSPHININE OXIDE DERIVATIVE AND PREPARATION METHOD THEREOF KNU-INDUSTRY COOPERATION FOUNDATION (KR) 2015-12-03 — — US disclosed
US-9073956-B1 Dihydro-1H-phosphole 1-oxide derivatives and preparation method thereof KNU-INDUSTRY COOPERATION FOUNDATION (KR) 2015-07-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344506-A1 NOVEL PHOSPHININE OXIDE DERIVATIVE AND PREPARATION METHOD THEREOF PHOSPHO1, PPIP5K2, ITPA ALDH1A1 3382/4885MEN1 902/4885KMT2A 3679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback